Research ArticleRetinopathy

Tyrosine kinase blocking collagen IV–derived peptide suppresses ocular neovascularization and vascular leakage

See allHide authors and affiliations

Science Translational Medicine  18 Jan 2017:
Vol. 9, Issue 373, eaai8030
DOI: 10.1126/scitranslmed.aai8030

Article Information

vol. 9 no. 373

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication August 13, 2016
  • Accepted for publication November 30, 2016

Author Information

  1. Raquel Lima e Silva1,2,*,
  2. Yogita Kanan1,2,*,
  3. Adam C. Mirando3,
  4. Jayoung Kim3,4,
  5. Ron B. Shmueli3,4,
  6. Valeria E. Lorenc1,2,
  7. Seth D. Fortmann1,2,
  8. Jason Sciamanna1,2,
  9. Niranjan B. Pandey3,5,
  10. Jordan J. Green1,3,4,6,
  11. Aleksander S. Popel3 and
  12. Peter A. Campochiaro1,2,
  1. 1Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  2. 2Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  3. 3Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  4. 4Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  5. 5AsclepiX Therapeutics, LLC, Baltimore, MD 21211, USA.
  6. 6Institute for Nanobiotechnology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  1. Corresponding author. Email: pcampo{at}jhmi.edu
    • * These authors contributed equally to this work.

    AltMetrics

    Article usage

    AbstractFullPDF
    Jan 20174614201379
    Feb 2017108162149
    Mar 201745860106
    Apr 20172571731
    May 20173152640
    Jun 20171931228
    Jul 20171851628
    Aug 20171801430
    Sep 201794810